UK Markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
515.85+2.40 (+0.47%)
As of 2:30PM EDT. Market open.
People also watch
Full screen
Previous close513.45
Bid514.95 x 100
Ask515.52 x 500
Day's range510.00 - 518.57
52-week range325.35 - 543.55
Avg. volume984,842
Market cap54.54B
PE ratio (TTM)62.44
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • MarketWatch2 hours ago

    Ignore the Obamacare fight in Congress and buy these 5 health-care stocks

    Regardless of how the debate over repealing the Affordable Care Act plays out, there are plenty of reason to like health care as a long-term investment, says Jeff Reeves.

  • Reuters5 days ago

    EU follows U.S. in backing Sanofi, Regeneron eczema drug

    The European Medicines Agency on Friday recommended approval of Regeneron Pharmaceuticals and Sanofi's new drug Dupixent for atopic dermatitis, a product many analysts see as the most important growth driver for the two companies. Recommendations from the agency's expert committee on new drugs are normally endorsed by the European Commission within a couple of months. Atopic dermatitis is a chronic type of skin inflammation also known as eczema, which in severe cases causes constant, often unbearable, itching.

  • Biotech Leadership Still In Force
    Investor's Business Daily5 days ago

    Biotech Leadership Still In Force

    A discussion of the leadership in the biotech group.